Home Blog Style 1

Начало/Home Blog Style 1

Avada includes a blog shortcode you can use anywhere on the site!

This blog shortcode was submitted by Markus, one of our Avada users and now on our developing team! It just goes to show what an awesome community we have, everyone is willing to help & share ideas. Dont wait, be a part of the Avada community today!

Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas

By |март 12th, 2015|Новини|

Pancreatic cancer mutational landscape Date: 04 Mar 2015 Topic: Translational research / Gastrointestinal cancers The researchers performed whole-genome sequencing and copy number variation analysis of 100 samples to reveal mutational landscape of pancreatic ductal adenocarcinomas.

Коментарите са изключени за Whole Genome Sequencing of Pancreatic Ductal Adenocarcinomas

New research reveals a connection between ccRCC and exposure to an ingredient in some herbal remedies

By |ноември 9th, 2014|Новини|

Date: 03 Nov 2014 Topic: Genitourinary cancers / Translational research New research by the international Cancer Genomics of the Kidney consortium (CAGEKID) reveals an important connection between clear cell renal cell cancer (ccRCC) and exposure

Коментарите са изключени за New research reveals a connection between ccRCC and exposure to an ingredient in some herbal remedies

New findings suggest why patients with early-stage tumours and EGFR mutations have worse outcomes with erlotinib

By |ноември 9th, 2014|Uncategorized|

Date: 30 Oct 2014 Topic: Translational research / Lung and other thoracic tumours / Anticancer agents & Biologic therapy David Carbone David Carbone Mutations in the epidermal growth factor receptor (EGFR) are the most common

Коментарите са изключени за New findings suggest why patients with early-stage tumours and EGFR mutations have worse outcomes with erlotinib

Novel Immunotherapy Vaccine May Decrease Recurrence in HER2 Positive Breast Cancer Patients

By |септември 23rd, 2014|Uncategorized|

Women who received trastuzumab as part of standard treatment show greatest benefit Date: 10 Sep 2014 Topic: Breast cancer / Immuno-oncology A new breast cancer vaccine candidate, GP2, provides further evidence of the potential of

Коментарите са изключени за Novel Immunotherapy Vaccine May Decrease Recurrence in HER2 Positive Breast Cancer Patients